Abstract:Honokiol, the main bioactive extract of Magnolia officinalis, exhibits extensive therapeutic actions. Its treatment for advanced non-small cell lung cancer is undergoing clinical trials in China. However, the published safety evaluation studies have focused on extract mixtures of Magnolia officinalis in which the honokiol content was well below the reported clinical dose of the honokiol monomer. Therefore, safety assessment of the honokiol monomer is urgently needed. Our previous studies have already demonstrated that a high dose of the honokiol microemulsion (0.6 mu g/mL) induces developmental toxicity in rats and zebrafish by inducing oxidative stress. By exploring the relationship between time and toxicity, we found that developmental toxic responses were stage-dependent. They mainly occurred within the first 24 h post fertilization (hpf) especially the first 12 hpf. In zebrafish, low doses of honokiol microemulsion (0.15, 0.21 mu g/mL) significantly decreased the levels of reactive oxygen species (ROS) and malondialdehyde (MDA) and increased the mRNA expression of bcl-2. In contrast, high dose (0.6 mu g/mL) increased the levels of ROS and MDA, decreased activities and mRNA expression of superoxide dismutase (SOD) and catalase (CAT), and increased mRNA expression of bax, c-jnk, p53 and bim. By acridine orange staining, we found that a high dose of honokiol microemulsion induced apoptosis mainly in zebrafish brain. In rat pheochromocytoma cells (PC12 cells), low doses of the honokiol microemulsion (1, 5, 10 mu M) exerted a protective effect against H2O2-induced oxidative damage while high doses (>= 20 mu M) induced oxidative stress, which further confirms the dual effects of honokiol microemulsion on nerve cells. These dual roles of the honokiol microemulsion in oxidation-reduction reactions and apoptosis may be regulated by the forkhead box class O (FoxO) signaling pathway. Due to the potential of developmental toxicity, we recommend that the administration of high dose honokiol microemulsion in pregnant women should be considered with caution.

Reactive oxygen species production and Bax/Bcl-2 regulation in honokiol-induced apoptosis in human hepatocellular carcinoma SMMC-7721 cells.

Honokiol Induces Apoptosis and Autophagy Via the ROS/ERK1/2 Signaling Pathway in Human Osteosarcoma Cells in Vitro and in Vivo.

Involvement of P38 Mitogen-Activated Protein Kinase Pathway in Honokiol-Induced Apoptosis in A Human Hepatoma Cell Line (Hepg2)

Protective effects of honokiol against oxidative stress-induced apoptotic signaling in mouse podocytes treated with H2O2.

Honokiol Induces Reactive Oxygen Species-Mediated Apoptosis in Candida Albicans Through Mitochondrial Dysfunction

Honokiol induces apoptosis of lung squamous cell carcinoma by targeting FGF2-FGFR1 autocrine loop.

Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO.

Honokiol Microemulsion Causes Stage-Dependent Toxicity Via Dual Roles in Oxidation-Reduction and Apoptosis through FoxO Signaling Pathway

Reactive oxygen species-mediated mitochondrial pathway is involved in Baohuoside I-induced apoptosis in human non-small cell lung cancer.

Honokiol Augments the Anti-Cancer Effects of Oxaliplatin in Colon Cancer Cells

PUB045 Anti-Tumor Effect of Honokiol in Lung Squamous Cell Carcinoma

Honokiol Mediates the Apoptosis of Human Cervical Carcinoma Hela Cells by Regulating P38 Signal Pathway

Honokiol Induces Ferroptosis In Colon Cancer Cells By Regulating Gpx4 Activity

Osu-03012, A Novel Celecoxib Derivative, Induces A Unique Autophagy-Like Cell Death In Human Hepatocellular Carcinoma Cells

Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells.

Mechanism of Apoptotic Induction on T24 Cells by Honokiol and Its Synergistic Anticancer Effect in Combination with Hydroxycamptothecin

Osu-03012, A Novel Celecoxib Derivative, Induces Reactive Oxygen Species-Related Autophagy In Hepatocellular Carcinoma

Honokiol ameliorates oxidative stress-induced DNA damage and apoptosis of c2c12 myoblasts by ROS generation and mitochondrial pathway

Honokiol Induces Paraptosis And Apoptosis And Exhibits Schedule-Dependent Synergy In Combination With Imatinib In Human Leukemia Cells

Effects of honokiol on proliferation and apoptosis of human cervical carcinoma cell line Hela in vitro

Honokiol Induces Caspase-Independent Paraptosis Via Reactive Oxygen Species Production That is Accompanied by Apoptosis in Leukemia Cells